AI GOVERNANCE PLATFORM · LIFE SCIENCES
Reign for Life Sciences
AI governance for your most regulated workflows. Built around personalized therapeutics, where every batch is the trial. FDA-aligned. 21 CFR Part 11 native. GxP-ready.
WHY NOW
AI moves daily. Validation cycles don't.
Life sciences AI deployments now span clinical decision support, multi-omics computational biology, regulatory submission packaging, and AI-assisted manufacturing. The pace of model change has overrun the validation cadence pharma quality systems were designed for.
Three converging forces are reshaping how regulated life sciences enterprises deploy AI:
The FDA PCCP framework operationalized.
Predetermined Change Control Protocols are no longer pilot. They are how AI-enabled medical devices and AI/ML SaMD must be governed across change cycles.
EU AI Act high-risk obligations from August 2026.
Pharmaceutical AI systems used in clinical, regulatory, or pharmacovigilance workflows fall into high-risk categories.
The validation gap is now a board-level risk.
Models change daily. Validation systems were built for quarterly. The gap compounds with every release.
WHERE REIGN STARTS
Built for personalized therapeutics, where every batch is the trial.
Personalized therapeutics. N-of-1 cell and gene therapies, autologous CAR-T, individualized neoantigen vaccines, AI-designed RNA payloads. Collapse the conventional separation between manufacturing, clinical trial, and pharmacovigilance. Each manufactured product is a clinical event for a single patient. The validation cadence pharma quality systems were designed for cannot carry this modality.
Reign is built for that compression. Continuous Observability and Continuous Assurance sit beneath every AI-assisted decision in your candidate design, release testing, and post-administration monitoring. Generating submission-ready evidence the FDA, EMA, Health Canada, and PMDA expect, at the cadence your therapeutic actually moves at.
- N-of-1 batch is the trial. Validation, manufacturing, and clinical evidence ride on the same ledger.
- Continuous PCCP-aligned change control, not quarterly remediation cycles.
- AI-assisted release testing with replayable evidence for every batch.
- Submission-ready Assurance Packs generated continuously. IND, BLA, and PCCP packages drawn directly from the spine.
Reign for Life Sciences sits at that intersection. Built for continuous, validated AI governance from day one.
TWO NAMED CAPABILITIES
Continuous Observability.
Continuous Assurance.
Two named outcomes Reign delivers. For every AI and agent decision in your clinical, regulatory, computational, and manufacturing workflows.
AI GATEWAY · MODEL RISK VALIDATION
Continuous Observability
Every prompt, model invocation, agent decision, drift event, and validation result. Visible in real time. Queryable after the fact. No black-box AI in clinical or regulatory workflows. No "we'll get back to you with the data" responses to FDA inspectors or audit committees.
“What is the system doing right now?”
AUDIT LEDGER (CAVR) · ASSURANCE PACKS
Continuous Assurance
Independent, attestable evidence. Submission-ready for IND, NDA, BLA, and PCCP packages. Mapped to FDA PCCP, 21 CFR Part 11, GxP, ICH Q9, EU AI Act, ISO 42001, NIST AI RMF, and ALCOA+. One evidence spine. Every regulatory framework.
“Can someone independent attest the AI is operating correctly. And prove it to the FDA?”
Reign: Personalized Therapeutics
Built for personalized therapeutics, where every batch is the trial.
N-of-1 cell and gene therapies, autologous CAR-T, individualized neoantigen vaccines, AI-designed RNA payloads. Modalities where the manufactured product is the trial.
The validation cadence pharma quality systems were designed for cannot carry this modality. Reign’s continuous Observability and Assurance spine generates submission-ready evidence at the cadence your therapeutic actually moves at. Not on quarterly remediation cycles.
Batch is the trial
Manufacturing, clinical, and pharmacovigilance ride on the same audit ledger. ALCOA+ integrity by default. Replay any AI-assisted decision back to the candidate-design substrate.
Continuous PCCP change control
Predetermined Change Control Protocols enforced as continuous validation gates. In-policy model changes ship at engineering cadence. Out-of-policy changes are blocked and routed to QA.
Submission-ready evidence
IND, BLA, and PCCP packages drawn directly from the spine. Format-aligned to FDA, EMA, Health Canada, and PMDA expectations. No manual evidence assembly between cycles.
“Validation evidence should be generated with the decision, not reconstructed against it. On a personalized therapeutic that’s not a preference. It’s the only model the therapeutic’s cadence can carry.”
iTmethods Design Partner Cohort thesis · Life Sciences track
WHAT THE CMO SEES
What changes for the Chief Medical Officer.
Four operational shifts you see once Reign is running beneath your N-of-1 program. Directional. Measured against the design partner cohort thesis, discussed during scoping.
Each shift is scoped against the design partner cohort thesis. The columns above describe the structural change. Quantified outcomes for your program are reviewed under NDA during scoping.
ONE SPINE. EVERY REGULATORY FRAMEWORK.
Native coverage of the regulatory landscape for life sciences AI.
Reign for Life Sciences maps natively to the frameworks that govern your AI deployments. Pharmaceutical, biotech, clinical. No custom integration. No translation. Assurance Packs generated from the spine in submission-ready format.
FDA PCCP
AI/ML-enabled medical devices and SaMD. Continuous change governance for FDA-aligned deployments.
21 CFR Part 11
Validation-native electronic signatures, audit trails, and ALCOA+ data integrity. Native compliance, not bolted on.
GxP
Validated workflows for manufacturing, lab, clinical, and distribution. AI-assisted GxP processes with continuous evidence generation.
ICH Q9
Risk-based AI quality management aligned with International Council for Harmonisation guidelines.
EU AI Act
Article 9 risk management, Article 10 data governance, Article 13 transparency. Annex IV technical documentation generated continuously.
ISO 42001
International standard for AI management systems. Reign provides the operating layer that ISO 42001-certified life sciences organizations require.
NIST AI RMF
Govern, Map, Measure, Manage. The four functions of NIST AI RMF, mapped to the Reign spine.
ALCOA+
Attributable, Legible, Contemporaneous, Original, Accurate. Plus Complete, Consistent, Enduring, Available. Native data integrity for regulated AI workflows.
Health Canada
Submission alignment for Health Canada Therapeutic Products Directorate and Biologics & Radiopharmaceutical Drugs Directorate. Assurance Packs format-aligned to Health Canada expectations alongside FDA, EMA, and PMDA equivalents.
"FDA-aligned". Never "FDA-Ready". Reign for Life Sciences provides the platform; certification status remains your organization's.
WHO REIGN SERVES
Built for the teams who deploy AI in regulated life sciences.
PRIMARY ROLE · LIFE SCIENCES
Chief Medical Officer
Accountable for clinical evidence, patient safety, and submission integrity across your AI-enabled therapeutic pipeline.
You carry the integrity of the trial. And on a personalized therapeutic, every batch is the trial. Reign gives you continuous, replayable evidence that every AI-assisted decision in candidate design, release testing, and post-administration monitoring is operating within policy and within validation. Submission cycle, PCCP change control, and inspection readiness sit on a single audit ledger your team queries directly, with ALCOA+ integrity guarantees and assurance packs generated continuously.
REGULATORY AFFAIRS
Submission-ready by default.
Generate IND, NDA, BLA, and PCCP submission packages directly from the evidence spine. Automated traceability from clinical AI decisions to regulatory documentation. No manual evidence assembly.
QA / QC
Validation-native, GxP-aligned.
ALCOA+ data integrity built in. Validated workflows for AI-assisted manufacturing, lab, and clinical processes. Continuous evidence generation. No quarterly remediation cycles.
CLINICAL DEVELOPMENT
Protocol-aware AI controls.
Study integrity preserved across AI-assisted clinical workflows. Real-time observability of every model decision affecting trial conduct or patient safety. Replayable evidence for audits.
COMPUTATIONAL BIOLOGY
Multi-modal data integrity.
Native support for leading life-sciences assay platforms and multi-modal data formats. Reproducibility at the model level. Integration with validated computational pipelines.
THE REIGN ARCHITECTURE, TUNED FOR LIFE SCIENCES
Same spine. Life-sciences-native extensions.
The same four-component governance spine that already runs at global banks and semiconductor leaders. Extended for your clinical, regulatory, and computational workflows.
COMPONENT 01
AI Gateway
Life Sciences extension:
Clinical-grade access controls. PII redaction tuned for protected health information. Validated access patterns for GxP environments.
COMPONENT 02
Model Risk Validation
Life Sciences extension:
FDA PCCP-fluent. Predetermined Change Control Protocols enforced as continuous validation gates. ICH Q9 risk management framework native.
COMPONENT 03
Audit Ledger (CAVR)
Life Sciences extension:
21 CFR Part 11 compliant electronic records. ALCOA+ integrity by default. Replayable evidence for FDA inspections and audit committee review.
COMPONENT 04
Assurance Packs
Life Sciences extension:
IND, NDA, BLA, PCCP submission packages. Format-aligned to FDA, EMA, Health Canada, PMDA expectations. No manual assembly.
Three Lines of Defense built in: 1st (Business & Operations) · 2nd (Risk & Quality) · 3rd (Internal Audit). With Independent Assurance to FDA, EMA, external auditors, and your board.
WHAT YOUR REGULATORY TEAM RECEIVES
Submission-ready. Generated continuously.
Every regulatory submission for AI-enabled life sciences workflows needs evidence of model behaviour, change control, validation status, and decision provenance. Reign generates that evidence pack directly from the audit ledger. Submission-ready by default.
Pack Contents
- Cover page · Submission ID · framework alignment · date range
- Model registry summary
- Change control log (PCCP-aligned)
- Validation status across all in-scope models
- Audit trail extracts (ALCOA+ aligned)
- Risk assessments mapped to ICH Q9
- Independent attestation references
Talk to our team about your submission cadence and evidence requirements
HOW WE WORK
Built with design partners. Co-designed. Co-validated. Shipped inside real regulated environments.
We are co-designing Reign for Life Sciences with the iTmethods Design Partner Cohort. Life sciences design partners working alongside the same governance spine that already runs in production at global banks and semiconductor leaders. Extended for your clinical, regulatory, and computational workflows.
Cohort engagements run as a joint working team inside your change control, GxP-validated environments, and audit posture from day one. We ship against your validation cadence, your change-control discipline, and your audit obligations. Not a generic services rhythm.
BioCompute is the sovereign Reign instance for Life Sciences (in development), anchored by the public intoDNA STRIDE platform partnership.
Operator heritage. Builder discipline. Cohort posture.
DEPLOYMENT OPTIONS
Deploy where your validated environment lives.
SaaS
Multi-tenant managed infrastructure. Fast onboarding. Cost-efficient.
Dedicated Cloud
Single-tenant managed infrastructure. Validated environment isolation.
Customer Cloud
Deployed in your AWS, Azure, or GCP account. Validation-native. GxP-ready.
Air-Gapped
Sovereign deployment. Zero external connectivity. For the most regulated environments.
Reign for Life Sciences runs anywhere. And runs best on Forge.
REIGN DESIGN PARTNER PROGRAM. LIFE SCIENCES TRACK
Apply to be a Reign Design Partner.
Life Sciences Track.
A small FY26 cohort. Cohort economics aligned for mutual investment. Discussed during scoping.
- Joint working team operating inside your change control
- Co-designed validation protocol and evidence standards
- Direct line to Reign's founding engineers
- Public reference (with mutual approval)
- Early access to platform extensions
Cohort closes September 30, 2026.
Apply to Reign Design Partner. Life Sciences TrackGO DEEPER
The deep specialty experience for life sciences lives at BioCompute.ai.
BioCompute.ai is that experience. Powered by BioCompute technology. Tools, workflows, and integrations purpose-built for your pharmaceutical, biotech, and clinical AI workloads.
Visit BioCompute.ai